Pilot study on the effect of flavonoids on arterial stiffness and oxidative stress in chronic kidney disease

doi:10.5527/wjn.v13.i3.95262

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1443)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

HTML

936

Figures (1-2)

128

Tables (1-4)

118

Sum=1211

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

139

Sum=181

Sep 25, 2024 (publication date) through Feb 6, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Nephrol. Sep 25, 2024; 13(3): 95262
Published online Sep 25, 2024. doi: 10.5527/wjn.v13.i3.95262

Table 4 Changes in parameters of oxidative stress at baseline and after treatment with flavonoids

Parameter	Baseline	End of study	P value
Proteinic carbonyls, nmol/mL	73.50 ± 18.65	52.54 ± 25.04	< 0.001
TPC, mg/mL	25.11 (16.95, 30.29)	31.91 (30.49, 47.51)	0.001
ΤAC, %	3.55 (1.15, 6.38)	12.51 (6.26, 17.66)	0.013

TAC: Total antioxidant capacity; TPC: Total phenolic compound.

Citation: Vagopoulou A, Theofilis P, Karasavvidou D, Haddad N, Makridis D, Tzimikas S, Kalaitzidis R. Pilot study on the effect of flavonoids on arterial stiffness and oxidative stress in chronic kidney disease. World J Nephrol 2024; 13(3): 95262
URL: https://www.wjgnet.com/2220-6124/full/v13/i3/95262.htm
DOI: https://dx.doi.org/10.5527/wjn.v13.i3.95262